Variant report
| Variant | rs1546136 |
|---|---|
| Chromosome Location | chr1:166533141-166533142 |
| allele | G/T |
| Outlinks | Ensembl UCSC |
- TF binding region (count:2)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:2 , 50 per page) page:
1
| No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
|---|---|---|---|---|---|---|
| 1 | CUX1 | chr1:166533129-166533166 | K562 | blood: | n/a | n/a |
| 2 | STAT3 | chr1:166533084-166533284 | MCF10A-Er-Src | breast: | n/a | n/a |
| No data |
(count:1 , 50 per page) page:
1
| No. | Distal block | Cell Line | Cell type | Cell Stage |
|---|---|---|---|---|
| 1 | chr1:166525439..166528045-chr1:166531507..166534045,2 | K562 | blood: |
| No data |
| No data |
| No data |
| Variant related genes | Relation type |
|---|---|
| FMO8P | TF binding region |
rSNPs within LD-proxies of this variant (count:6)
| rs_ID | r2[population] |
|---|---|
| rs10918526 | 0.86[AMR][1000 genomes];0.87[EUR][1000 genomes] |
| rs1546137 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes] |
| rs198982 | 0.84[AMR][1000 genomes];0.87[EUR][1000 genomes] |
| rs7535888 | 0.89[AMR][1000 genomes];0.86[EUR][1000 genomes] |
| rs7543561 | 0.93[AFR][1000 genomes];0.91[AMR][1000 genomes];0.88[EUR][1000 genomes] |
| rs7546743 | 0.89[AMR][1000 genomes];0.87[EUR][1000 genomes] |
Variant overlapped rSNPs/rCNVs (count:10 , 50 per page) page:
1
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | nsv916491 | chr1:166000783-166948513 | Bivalent/Poised TSS Weak transcription Active TSS Enhancers Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Strong transcription Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 38 gene(s) | inside rSNPs | diseases |
| 2 | esv2757759 | chr1:166491879-166650985 | Enhancers Flanking Active TSS Weak transcription ZNF genes & repeats Bivalent Enhancer Active TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 4 gene(s) | inside rSNPs | diseases |
| 3 | esv2758975 | chr1:166491879-166650985 | ZNF genes & repeats Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Active TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 4 gene(s) | inside rSNPs | diseases |
| 4 | esv3375452 | chr1:166495343-166534187 | Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | inside rSNPs | diseases |
| 5 | esv3440978 | chr1:166498343-166533931 | Weak transcription Enhancers ZNF genes & repeats | TF binding regionChromatin interactive region | 2 gene(s) | inside rSNPs | diseases |
| 6 | nsv872511 | chr1:166505186-166590046 | ZNF genes & repeats Enhancers Weak transcription Flanking Active TSS | TF binding regionCpG islandChromatin interactive region | 3 gene(s) | inside rSNPs | diseases |
| 7 | nsv872512 | chr1:166532565-166581706 | Enhancers Weak transcription Flanking Active TSS | TF binding regionCpG islandChromatin interactive region | 3 gene(s) | inside rSNPs | diseases |
| 8 | nsv872513 | chr1:166532565-166590046 | Weak transcription Enhancers Flanking Active TSS | TF binding regionCpG islandChromatin interactive region | 3 gene(s) | inside rSNPs | diseases |
| 9 | nsv872514 | chr1:166532565-166595209 | Weak transcription Enhancers Flanking Active TSS Active TSS | TF binding regionCpG islandChromatin interactive region | 3 gene(s) | inside rSNPs | diseases |
| 10 | nsv872515 | chr1:166532565-166595692 | Enhancers Flanking Active TSS Weak transcription Active TSS | TF binding regionCpG islandChromatin interactive region | 3 gene(s) | inside rSNPs | diseases |
| No data |
Chromatin state (count:0 , 50 per page) page:
| No data |
